Introduction
It is increasingly recognized that exacerbation is a key event in COPD because of its significant negative impacts on patients' quality of life and poor prognosis. [1] [2] [3] It was reported that exacerbations are associated with accelerated lung function loss in patients with COPD, particularly those with mild disease. 4 Many studies have reported that an increased frequency of exacerbation is associated with more severe airflow obstruction in patients with COPD. 5, 6 Bronchial wall thickness and total lung emphysema percentage were associated with COPD exacerbation frequency. 7 The clinical symptoms of cough and sputum are associated with the frequency of exacerbation.
Identification of risk factors for exacerbation of COPD is clinically important because it enables adequate precautionary measures, such as pharmacologic therapy and vaccine, in patients predisposed to COPD exacerbation.
The forced oscillation technique (FOT) is a noninvasive procedure that measures lung mechanics using sinusoidal sound waves at two or three different frequencies simultaneously. FOT parameters of respiratory system resistance (Rrs) and respiratory system reactance (Xrs) were measured by the application of a sine wave of airflow to the mouth at the resonant frequency of the respiratory system according to the principle established by Fisher et al. 10 Rrs components include the resistance at 5 Hz (R5), the resistance at 20 Hz (R20), and the difference between R5 and R20 (R5−R20). Xrs components include the reactance at 5 Hz (X5), the differences between inspiratory and expiratory Xrs (ΔXrs), the resonant frequency (Fres), and the area of low reactance (ALX). FOT represents an alternative modality to conventional pulmonary function tests because of its sensitivity in detecting peripheral airway obstruction. In addition, it can be performed independent of the patient's efforts with minimal need for their cooperation. 11, 12 Therefore, FOT can be used in elderly patients and those with physical and cognitive limitations, and it would be helpful for these patients if FOT can detect exacerbations of COPD.
The utility of FOT has been reported most frequently in relation to asthma and COPD. Respiratory impedance (Rrs and Xrs) in patients with COPD is generally correlated with Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging, classified according to the degree of airway obstruction. 13 Moreover, FOT can detect the pharmacologic effects of bronchodilators on small airways in patients with COPD despite an absence of change in forced expiratory volume in 1 second (FEV 1 ).
14 ΔXrs, particularly ΔX5, can be used for discrimination between COPD and asthma 15, 16 or for detection of expiratory flow limitation (EFL) that indicates dynamic hyperinflation in COPD. 17, 18 In a previous study, it was reported that increased Rrs is associated with frequent exacerbations in severe asthma. 19 However, the association between respiratory impedance and exacerbations in patients with COPD has not been determined.
We hypothesized that respiratory impedance as assessed by FOT is associated with the increased risk of exacerbations independently from respiratory parameters as measured by conventional spirometry in patients with COPD. To prove this hypothesis, we evaluated the relationship between respiratory impedance as measured by FOT and the risk of exacerbation in patients with COPD.
Materials and methods subjects and study design
This was a single-centered, retrospective case-control study. The analysis was based on data obtained from 310 patients with COPD (defined by GOLD) who presented at Showa University Hospital (Tokyo, Japan) from September 2014 through January 2015. All patients were confirmed that their FEV 1 /forced vital capacity ratio (FEV 1 /FVC) ,0.7. As shown in Figure 1 , we excluded some of the patients for the following reasons: 142 patients concurrently had chronic respiratory disease, 4 patients were receiving regularly oral corticosteroid therapy, and 45 patients did not undergo respiratory function testing. The remaining 119 patients fulfilled our study criteria and were assigned into 2 groups: patients 
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association between FOT and exacerbations of COPD who had one or more exacerbations within the past 2 years from the last visit (Exacerbators) and patients who had no exacerbations within the past 2 years from the last visit (Nonexacerbators). We defined an exacerbation as an acute event that fulfilled the following criteria: 20 1) clinically significant change in baseline dyspnea, cough, and/or sputum, 2) presentation at the emergency department because of a need to receive oral corticosteroids or systemic corticosteroid therapy.
We collected data including exacerbations, age, gender, height, body weight, smoking history, blood counts, medical history, and respiratory function from the 119 patients. The white blood cell (WBC) count, absolute eosinophil count, and relative eosinophil count were determined within 5 months before enrollment. The blood counts measured when the patients had infectious diseases were excluded. FOT and spirometry were also performed when the patients were free from infectious diseases and exacerbations for at least 2 months.
The study was performed in accordance with the principles of the Declaration of Helsinki. The protocol was approved by the ethics committee of Showa University School of Medicine on March 25, 2016 (No 2029 , and all subjects gave their written informed consent.
FOT
Rrs and Xrs were assessed by FOT (Mostgraph-01, Chest MI, Inc., Tokyo, Japan) in all subjects. All FOT assessments were performed by skilled clinical laboratory technicians. FOT was performed before spirometry in all patients to avoid bronchospasm caused by forceful expiration and inspiration. The subjects were requested to sit down, slightly stretch their neck, wear a nose clip, and put a mouthpiece into their mouth, without leaving any space between the lips and the mouthpiece. During impedance measurements, all subjects held their cheeks firmly with their hands. The measurement was conducted three times in a row, and the best data were adopted. We accepted resting ventilation with a coherence of 0.7 or higher and excluded the value when resting ventilation was unstable with patients' coughing, swallowing, phonation, or breath holding.
spirometry
Respiratory function was assessed with the use of a spirometer (CHESTAC-8900, Chest MI, Inc., Tokyo, Japan) in all subjects. The forced expiration maneuver was conducted with the subject in a standing position. Measurements were obtained in accordance with the guidelines for pulmonary function tests issued by the Japanese Respiratory Society. % predicted FVC and % predicted FEV 1 
Results

Patients
We studied 119 patients who fulfilled the study criteria. The characteristics of the study patients are summarized in 
spirometry and FOT measurements
Comparisons of spirometry data and FOT parameters between the three groups classified by severity are shown in Table S1 . There were significant differences in all parameters obtained by spirometry and FOT between the groups. [1.19, 16 .61], P=0.008) between the two groups. Meanwhile, there were no significant differences in R5−R20 and ΔX5 between the two groups. We also compared Rrs and Xrs between the two groups by subgroup of disease severity, and the results are shown in Table 4 
Discussion
Exacerbation is a key event in COPD because it accelerates lung function loss and decreases patients' quality of life. [1] [2] [3] The present study showed the differences in respiratory impedance between Exacerbators and Nonexacerbators in patients with COPD as measured by FOT. The values of R20, Fres, and ALX were higher in Exacerbators than in Nonexacerbators, while that of X5 was lower. To our knowledge, this is the first study to demonstrate differences in FOT parameters between Exacerbators and Nonexacerbators in patients with COPD.
The frequency of COPD exacerbation generally depends on the disease severity, classified as airflow limitation measured by the use of conventional spirometry. In the present study, lower pulmonary function as assessed by FVC and FEV 1 , older age, and higher WBC count were associated with exacerbations in patients with COPD. In line with our results, the ECLIPSE study demonstrated that disease severity and an elevated WBC count were associated exacerbations in patients with COPD; in addition, prior exacerbations, a history of gastroesophageal reflux, symptoms of heartburn, and a poorer quality of life were also found to be determinants of exacerbations. 22 In particular, a history of exacerbations in the preceding year was the best determinant of exacerbations. In the present study, we demonstrated the possibility of FOT as a novel and objective indicator for the detection of exacerbation in COPD, representing a viable alternative to spirometry. Intriguingly, Gonem et al reported that, in patients with severe asthma, airway constriction as measured by FOT was associated with an exacerbation-prone phenotype. 19 Recently, the importance of identifying patients with mild airway obstruction, such as those classified as GOLD stages I and II, has been recognized because of potential future impairment of their health status. 23 In addition, the Genetic Epidemiology of COPD study introduced novel evidence that exacerbations accelerate lung function loss in patients with COPD, particularly in those with mild disease. 3 Our study showed that among the subgroup of patients with stage II COPD, there were significant differences in FOT parameters between Exacerbators and Nonexacerbators despite no significant difference in respiratory function as measured by spirometry. This indicates that FOT can discriminate an 
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Notes: all values are median (interquartile range) unless otherwise stated. exacerbator group: consisted of patients experiencing one or more exacerbations within 2 years. nonexacerbator group: consisted of patients who had never experienced exacerbation within 2 years. P-values represent statistical analyses between exacerbator and nonexacerbator groups. The analyses of FOT parameters are adjusted for age, gender, height, and smoking status. *P,0.05.
Abbreviations: FOT, forced oscillation technique; FeV
1
, forced expiratory volume in 1 second; FVC, forced vital capacity; r5, resistance at 5 hz; r20, resistance at 20 hz; r5-r20, difference between r5 and r20; X5, reactance at 5 hz;
Fres, resonant frequency; alX, reactance area; ΔX5, difference between inspiratory and expiratory respiratory system reactance.
exacerbation-prone phenotype among patients with the same grade of mild severity. We believe that this is the key findings of our study. FOT has been reported to be more sensitive than spirometry in detecting COPD and in assessing the effects of bronchodilators. 24, 25 However, our findings do indicate the utility of FOT but do not necessarily confirm its superiority over conventional spirometry in assessing exacerbation in patients with COPD.
Dellacà et al reported that ΔXrs can be used to detect the presence of EFL, which is a characteristic feature in patients with moderate-to-severe COPD with dynamic hyperinflation and the loss of lung elastic recoil. 17 Previous studies reported that EFL is associated with certain symptoms, especially dyspnea, and with exacerbations of COPD. 26, 27 In the present study, it was shown that ΔX5 was reduced more in Exacerbators than in Nonexacerbators, among all patients and among those with stage II COPD, but without statistical differences. Thus, the presence of EFL may not be associated with the ability of FOT to discriminate between Exacerbators and Nonexacerbators in patients with stage II COPD. Xrs is supposed to reflect the compliance and inertial properties of the respiratory system; changes in Xrs in pulmonary disease are dominated by respiratory compliance but not inertial properties. 28 Compliance is primarily associated with the lung periphery. A study conducted by Borrill et al showed that changes in X5 and Fres induced by the administration of bronchodilators were related to small airway bronchodilation, causing a reduction in hyperinflation and improvement in lung compliance. 29 Therefore, slight perturbations of the small airways might have resulted in differences in Xrs between Exacerbators and Nonexacerbators in patients with stage II COPD, despite no significant differences in respiratory function as measured by spirometry. However, the reason why FOT discriminated between Exacerbators and Nonexacerbators in this study has not fully been elucidated.
In the present study, Xrs values became more negative in patients with higher GOLD staging. This is consistent with a previous study conducted by Di Mango et al. 30 They also reported that Xrs was useful in assessing airway obstruction in patients with more advanced COPD. Our study did not show any clinical utility of FOT in discriminating between Exacerbators and Nonexacerbators in patients with severe COPD. In this study, ROC curve analysis showed that AUC values were higher in Xrs, particularly X5 and Fres, than in Rrs, indicating that Xrs is more closely associated with exacerbation-prone phenotype of COPD than Rrs. In accordance with our results, Stevenson et Abbreviations: alX, reactance area; aUC, area under the curve; FeV 1 , forced expiratory volume in 1 second; FOT, forced oscillation technique; Fres, resonant frequency; FVC, forced vital capacity; rOC, receiver operating characteristic; r5, resistance at 5 hz; r20, resistance at 20 hz; r5-r20, differences between r5 and r20; ΔX5, difference between inspiratory and expiratory respiratory system reactance; X5, reactance at 5 hz.
was a significant improvement in X5 but not in R5 during recovery from exacerbation of COPD. 31 In addition, previous studies showed that Xrs was more effective than Rrs in the assessment of degree of airflow limitation and air trapping in patients with COPD. 13, 32 Previous studies showed significant correlations between FOT parameters and respiratory function as measured by spirometry in patients with geriatric COPD. 13, 32 Therefore, FOT, rather than spirometry, can be used to assess airway obstruction in patients who have difficulty with forced expiration. FOT is a useful tool in diagnosing COPD, evaluating disease severity, formulating prognosis, and evaluating response to therapy, similar to spirometry. Amaral et al recently introduced automatic classifiers to simplify the clinical use and increase the accuracy of FOT in the categorization of airway obstruction level in patients with COPD. Our study has some limitations. First, we could not exclude the influence of patients with asthma-COPD overlap (ACO), although patients who had evident asthmatic components, such as airway hyper-responsiveness, were excluded. Studies have shown that patients with ACO have more frequent exacerbations than those with COPD only. 34, 35 However, at present, there is no definition or basis for excluding a patient with ACO. Second, we found no difference in respiratory impedance between Exacerbators and Nonexacerbators among patients with stage III and IV COPD. Although it cannot be concluded whether FOT can discriminate an exacerbation-prone phenotype among patients with severe COPD, it may be superior in discriminating an exacerbationprone phenotype in patients with nonsevere COPD compared to those with severe COPD. Third, this was a single-centered retrospective study and the sample size was relatively small. Therefore, we cannot conclude whether FOT parameters can predict exacerbations of COPD in clinical practice, particularly in patients with moderate COPD. For this confirmation, prospective studies including a greater number of subjects are necessary to verify our results.
Conclusion
We found significant differences in FOT parameters between Exacerbators and Nonexacerbators, despite no significant differences in respiratory function as measured by spirometry among patients with stage II COPD. FOT can aid therapeutic intervention aimed at the avoidance of COPD exacerbation. Prospective studies are required to further explore the utility of FOT, such as its superiority to spirometry, in patients with COPD. 
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